ERBB2 and non-small cell lung carcinoma: In NSCLC, increased copy number of the HER2 gene is associated with gefitinib sensitivity in EGFR-positive patients, thus supporting the use of HER2 FISH analysis for selection of patients for TK inhibitor (TKI) therapies [16].